Clinical Research Management, Inc. (ClinicalRM), a full-service Contract Research Organization providing services for basic and applied research, clinical trials, and regulatory support, announced today it was awarded a USAMMDA contract. With this contract, ClinicalRM will provide regulatory support personnel and may also provide equipment, supplies, facilities, transportations, tools, and materials necessary to support USAMMDA’s mission. The contract award number is W81XWH-13-C-0003, and is effective for 5 years, including option renewals, as of November 1, 2012.
USAMMRD supports ongoing efforts to develop new drugs, vaccines, devices, and medical support equipment that enhance readiness, endures the provision of the highest quality medical care to the Department of Defense (DoD), and maximizes the survival of medical casualties on the battlefield.
“ClinicalRM is honored to continue the support of the important USAMMDA mission throughthis new contract,” said Edie Druktenis, ClinicalRM Program Manager. “Our staff is highly qualified and have proven to be a great asset to the mission over the last couple of years to move solutions forward, developing medical material to protect and sustain the warfighter.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.